心肌JAK-STAT信号通路的研究进展

JAK-STAT信号通路介导心肌细胞的生长、存活和凋亡,并参与血管生成的调节,在心脏疾病的发生机制中发挥重要作用。压力负荷导致的心肌肥大、心力衰竭、缺血预处理诱导的心肌保护,以及缺血-再灌注引起的心功能障碍,都与这一信号通路密切相关。血管紧张素Ⅱ(ANGⅡ)与JAK-STAT信号通路相互作用加重缺血性心肌损伤;激活gpl30-STAT3信号通路对心力衰竭和缺血性心脏病的防治具有重要意义。     

JAK/STAT信号通路及其对昆虫免疫的调控

JAK/STAT信号通路参与细胞的生长、分化、凋亡和免疫调节等重要的生物学过程,是细胞因子介导的最重要的信号转导途径之一。在昆虫中,JAK/STAT是一条相对保守的信号途径,与Toll途径和Imd途径共同作为主要免疫途径以抵御病原物入侵,在昆虫免疫、激素调控和其他生理调节过程中发挥着十分重要的作用。本文介绍了细胞因子受体超家族、JAKs家族、STATs家族和JAK/STAT信号通路及其负反馈调节的作用机制,分析了寄生物、病毒和真菌感染昆虫时,JAK/STAT信号通路的重要功能及最新研究进展,并提出了JAK/STAT信号通路研究中尚待解决的问题,以期为该领域后续深入研究提供方向和参考。     

NOK通过JAK2依赖性方式激活STAT3信号通路

NOK能激活包含JAK-STAT信号通路在内的多种促细胞有丝分裂信号通路.研究发现,在人胚肾细胞(HEK293T)中,NOK与STAT3具有直接的相互作用.进一步的实验表明,NOK能同STAT3蛋白除螺旋结构域及c端结构域外的其他4个结构域发生相互作用,而NOK的胞内区则介导了NOK同STAT3的相互作用.同时,免疫共沉淀实验显示,NOK能与JAK2发生相互作用.重要的是,共同表达NOK与JAK2蛋白对STAT3信号通路能产生一种非常显著的协同激活作用,但当共同表达NOK和JAK2的激酶活性缺失突变体时,并不产生这种协同激活效应.综上,实验结果显示,NOK可能同STAT3和JAK2形成一个复合物,通过JAK2依赖性方式激活STAT3信号通路.     

Leptin介导的JAK/STAT信号通路对脂类代谢调节的研究进展

Leptin介导的JAK/STAT信号通路主要参与脂类代谢的调节。JAK/STAT信号通路激活后,CPT-1的表达水平升高,通过促进脂肪酸分解而参与脂类代谢的调节。本文主要介绍了近年来关于leptin介导的JAK/STAT信号通路的组成、作用机制、活性调节和leptin与受体结合激活细胞内多个信号通路如JAK/STAT、PI3K/Akt、MAPK等,以及这些信号通路对脂类代谢调节的最新研究进展。     

STAT3与在肿瘤耐药中的研究进展

STAT3是信号转导与转录活化蛋白(STATs)家族的重要一员,是一种存在于胞浆并在激活后能够转入核内与DNA结合的蛋白家族,具有信号转导和转录调控双重功能。STAT3在多种肿瘤组织与细胞系中异常表达,并与肿瘤的增殖分化、细胞凋亡密切相关。肿瘤耐药是其治疗失败的重要原因,STAT3能够通过多种途径介导肿瘤耐药。因而,STAT3在近年的抗肿瘤研究中备受关注,成为肿瘤治疗的良好靶点,由传统药物与STAT3抑制剂组成的新型治疗方案使得肿瘤患者大大受益。然而,STAT3介导肿瘤耐药的机制还不是很明确,需要进一步研究。本文就近年来一些化疗药物和靶向药物耐药的发生,对STAT3介导耐药的作用进行综述。     

Leptin介导JAK/STAT信号通路对猪皮下前脂肪细胞脂类代谢调控的研究

以猪原代皮下前脂肪细胞为研究材料,检测Leptin介导JAK/STAT信号通路中基因表达水平,旨在阐明Leptin介导JAK/STAT信号通路对脂肪代谢的分子机制。用0和100 ng/mL Leptin分别处理脂肪细胞48 h,油红O染色鉴定脂肪细胞,试剂盒测定细胞中甘油三酯和游离脂肪酸含量,Real-time PCR方法检测皮下前脂肪细胞中JAK/STAT信号通路中基因表达水平。研究结果表明:皮下前脂肪细胞中,Leptin组甘油三酯含量均显著低于对照组(P<0.05),脂肪酸含量均低于对照组;JAK/STAT信号通路中LepR、JAK2、STAT3、CPT-1、ACOX1和PGC-1α基因的表达量均显著高于对照组(P<0.05);LepR、JAK2、STAT3、CPT-1、ACOX1和PGC-1α基因表达量均与甘油三酯和游离脂肪酸含量呈显著负相关(P<0.05)。该研究结果表明,Leptin激活皮下前脂肪细胞中JAK/STAT信号通路,上调通路相关基因的表达,促进甘油三酯分解及脂肪酸氧化,降低细胞中甘油三酯和游离脂肪酸含量。     

Regulating RISK: a role for JAK-STAT signaling in postconditioning?

Postconditioning (POC), a novel strategy of cardioprotection against ischemia-reperfusion injury, is clinically attractive because of its therapeutic application at the predictable onset of reperfusion. POC activates several intracellular kinase signaling pathways, including phosphatidylinositol 3-kinase (PI3K)-Akt (RISK). The regulation of POC-induced survival kinase signaling, however, has not been fully characterized. JAK-STAT activation is integral to cardiac ischemic tolerance and may provide upstream regulation of RISK. We hypothesized that POC requires the activation of both JAK-STAT and RISK signaling. Langendorff-perfused mouse hearts were subjected to 30 min of global ischemia and 40 min of reperfusion, with or without POC immediately after ischemia. A separate group of POC hearts was treated with AG 490, a JAK2 inhibitor, Stattic, a specific STAT3 inhibitor, or LY-294002, a PI3K inhibitor, at the onset of reperfusion. Cardiomyocyte-specific STAT3 knockout (KO) hearts were also subjected to non-POC or POC protocols. Myocardial performance (+dP/dt(max), mmHg/s) was assessed throughout each perfusion protocol. Phosphorylated (p-) STAT3 and Akt expression was analyzed by Western immunoblotting. POC enhanced myocardial functional recovery and increased expression of p-STAT3 and p-Akt. JAK-STAT inhibition abrogated POC-induced functional protection. STAT3 inhibition decreased expression of both p-STAT3 and p-Akt. PI3K inhibition also attenuated POC-induced cardioprotection and reduced p-Akt expression but had no effect on STAT3 phosphorylation. Interestingly, STAT3 KO hearts undergoing POC exhibited improved ischemic tolerance compared with KO non-POC hearts. POC induces myocardial functional protection by activating the RISK pathway. JAK-STAT signaling, however, is insufficient for effective POC without PI3K-Akt activation.     

The JAK-STAT signaling pathway: input and output integration

Universal and essential to cytokine receptor signaling, the JAK-STAT pathway is one of the best understood signal transduction cascades. Almost 40 cytokine receptors signal through combinations of four JAK and seven STAT family members, suggesting commonality across the JAK-STAT signaling system. Despite intense study, there remain substantial gaps in understanding how the cascades are activated and regulated. Using the examples of the IL-6 and IL-10 receptors, I will discuss how diverse outcomes in gene expression result from regulatory events that effect the JAK1-STAT3 pathway, common to both receptors. I also consider receptor preferences by different STATs and interpretive problems in the use of STAT-deficient cells and mice. Finally, I consider how the suppressor of cytokine signaling (SOCS) proteins regulate the quality and quantity of STAT signals from cytokine receptors. New data suggests that SOCS proteins introduce additional diversity into the JAK-STAT pathway by adjusting the output of activated STATs that alters downstream gene activation.